$11.81
4.19%
NYSE, Oct 03, 10:00 pm CET

Avanos Medical, Inc. Stock price

$11.79
-0.56 4.53% 1M
-2.24 15.97% 6M
-4.13 25.94% YTD
-11.23 48.78% 1Y
-10.62 47.39% 3Y
-22.56 65.68% 5Y
-17.49 59.73% 10Y
-29.21 71.24% 20Y
NYSE, Closing price Fri, Oct 03 2025
+0.46 4.06%

Key metrics

Basic
Market capitalization
$547.1m
Enterprise Value
$561.9m
Net debt
$14.8m
Cash
$90.3m
Shares outstanding
46.3m
Valuation (TTM | estimate)
P/E
negative | 14.5
P/S
0.8 | 0.8
EV/Sales
0.8 | 0.8
EV/FCF
6.4
P/B
0.7
Financial Health
Equity Ratio
71.8%
Return on Equity
-47.3%
ROCE
4.9%
ROIC
-
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$692.5m | $689.5m
EBITDA
$86.8m | $152.2m
EBIT
$44.7m | $128.9m
Net Income
$-463.2m | $37.6m
Free Cash Flow
$87.7m
Growth (TTM | estimate)
Revenue
1.5% | 0.3%
EBITDA
20.2% | 68.7%
EBIT
67.4% | 188.4%
Net Income
-6,115.6% | 109.6%
Free Cash Flow
108.8%
Margin (TTM | estimate)
Gross
53.8%
EBITDA
12.5% | 22.1%
EBIT
6.5%
Net
-66.9% | 5.5%
Free Cash Flow
12.7%
More
EPS
$-10.0
FCF per Share
$1.9
Short interest
9.8%
Employees
2k
Rev per Employee
$310.0k
Show more

Is Avanos Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Avanos Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Avanos Medical, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Avanos Medical, Inc. forecast:

Hold
50%
Sell
50%

Financial data from Avanos Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
693 693
1% 1%
100%
- Direct Costs 320 320
6% 6%
46%
373 373
2% 2%
54%
- Selling and Administrative Expenses 312 312
1% 1%
45%
- Research and Development Expense 24 24
8% 8%
3%
87 87
20% 20%
13%
- Depreciation and Amortization 42 42
7% 7%
6%
EBIT (Operating Income) EBIT 45 45
67% 67%
6%
Net Profit -463 -463
6,116% 6,116%
-67%

In millions USD.

Don't miss a Thing! We will send you all news about Avanos Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avanos Medical, Inc. Stock News

Positive
Seeking Alpha
about 19 hours ago
Avanos Medical is deeply undervalued, with strong international expansion, aggressive M&A strategy, and a new CFO poised to drive inorganic growth. AVNS operates in high-growth markets, maintains a solid balance sheet with low debt, and trades at a significant discount to sector peers on earnings and book value. Ongoing transformation, divestitures, and stock repurchases are expected to enhance...
Neutral
PRNewsWire
21 days ago
ALPHARETTA, Ga. , Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas.
Positive
Seeking Alpha
about one month ago
Avanos Medical, Inc. appears deeply undervalued after years of restructuring, with a potential stabilization in sales and earnings projected for 2025. Recent tariff impacts and lowered guidance seem fully priced in, setting the stage for upside surprises and a share price rally into 2026. Insider buying and improving technical indicators suggest a sea change for investor confidence could be next.
More Avanos Medical, Inc. News

Company Profile

Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Head office United States
CEO David Pacitti
Employees 2,227
Founded 2014
Website avanos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today